BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20353368)

  • 41. Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline.
    Terrault NA
    Hepatology; 2018 Nov; 68(5):2035-2038. PubMed ID: 29672896
    [No Abstract]   [Full Text] [Related]  

  • 42. HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs).
    La Manna G
    J Nephrol; 2018 Apr; 31(2):185-187. PubMed ID: 29411309
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of chronic hepatitis B: consensus guidelines.
    Sherman M; Shafran S; Burak K; Doucette K; Wong W; Girgrah N; Yoshida E; Renner E; Wong P; Deschênes M
    Can J Gastroenterol; 2007 Jun; 21 Suppl C(Suppl C):5C-24C. PubMed ID: 17568823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Appraisal, diagnosis and therapy of chronic metabolic acidosis in Germany].
    Geiger H; Jung O
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1880-4. PubMed ID: 23975846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overcoming barriers to care for hepatitis C.
    Clark PJ; Muir AJ
    N Engl J Med; 2012 Jun; 366(26):2436-8. PubMed ID: 22738095
    [No Abstract]   [Full Text] [Related]  

  • 46. Standards of hepatitis C treatment. Recommendations of Polish Group of Experts--2014.
    Halota W; Flisiak R; Boroń-Kaczmarska A; Juszczyk J; Pawłowska M; Simon K; Tomasiewicz K; Małkowski P
    Przegl Epidemiol; 2014; 68(3):469-74, 571-6. PubMed ID: 25394304
    [No Abstract]   [Full Text] [Related]  

  • 47. Kidney Transplants for Patients With Hepatitis C Virus Infection.
    Ann Intern Med; 2018 Aug; 169(4):. PubMed ID: 29987320
    [No Abstract]   [Full Text] [Related]  

  • 48. The Latin American Association for the Study of the Liver in its meeting on diagnosis, management and treatment of hepatitis C.
    Méndez-Sánchez N
    Ann Hepatol; 2010; 9 Suppl():7. PubMed ID: 20713989
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of Graves' disease: an overview and comparison of clinical practice guidelines with actual practice trends.
    Muldoon BT; Mai VQ; Burch HB
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):495-516. PubMed ID: 24891174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Singh N; Dies D; Samant H
    Transplantation; 2017 May; 101(5):e192. PubMed ID: 28437390
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatitis C virus: its prevalence, implications and management.
    Rogers G; Campbell L
    Nurs Times; 2003 Dec 16-2004 Jan 5; 99(50):30-1. PubMed ID: 14705419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013.
    Umar M; Khan AG; Abbas Z; Arora S; Asifabbas N; Elewaut A; Esmat G; Foster G; Fried M; Goh KL; Hamama TB; Imawari M; Isakov V; Krabshuis J; LaBrecque D; Lemair A; Malfertheiner P; Ryder S; Schiedermaier P; Stimac D; Tandon R; Villamil F; Zapata R; Ferenci P;
    J Clin Gastroenterol; 2014 Mar; 48(3):204-17. PubMed ID: 24504078
    [No Abstract]   [Full Text] [Related]  

  • 53. New guidelines on hepatitis C.
    Tanne JH
    BMJ; 1997 Apr; 314(7087):1070. PubMed ID: 9133883
    [No Abstract]   [Full Text] [Related]  

  • 54. Hepatitis C: watch for the many or treat for the few?
    Rogers S
    JAMA; 1996 Jul 24-31; 276(4):280-1. PubMed ID: 8656532
    [No Abstract]   [Full Text] [Related]  

  • 55. Landscape of Kidney Transplantation in Patients With Compensated Liver Disease: Results of a Survey of Transplant Surgeons in the United States.
    Sibulesky L; Hansen RN; Leca N; Blosser C; Rahnemai-Azar AA; Montenovo MI; Dick AA; Bakthavatsalam R; Rayhill S; Bhattacharya R; Reyes JD
    Transplant Proc; 2016 Dec; 48(10):3268-3273. PubMed ID: 27931567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Key issues in diagnosing and treating hepatitis C infection.
    Hainsworth T
    Nurs Times; 2006 Jun 13-19; 102(24):23-4. PubMed ID: 16827041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of chronic hepatitis C: consensus guidelines.
    Sherman M; Shafran S; Burak K; Doucette K; Wong W; Girgrah N; Yoshida E; Renner E; Wong P; Deschênes M
    Can J Gastroenterol; 2007 Jun; 21 Suppl C(Suppl C):25C-34C. PubMed ID: 17568824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.
    Kidney Disease: Improving Global Outcomes (KDIGO)
    Kidney Int Suppl; 2008 Apr; (109):S1-99. PubMed ID: 18382440
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis C: medical information update. Canadian Liver Foundation. National Hepatitis C Education Program.
    ;
    Can J Public Health; 2000; 91 Suppl 1(Suppl 1):S4-9. PubMed ID: 11059122
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatitis C: How to fine-tune your approach.
    Wangensteen L; Wangensteen KJ; Evans SG; Everts LE; Trooskin SB
    J Fam Pract; 2015 Sep; 64(9):535-40. PubMed ID: 26546955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.